IRIS - Res&Arch Institutional Research Information System - Research & Archive

TABARRINI, Oriana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.389
NA - Nord America 5.912
EU - Europa 4.646
SA - Sud America 581
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 17.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.810
CN - Cina 2.797
SG - Singapore 1.761
IT - Italia 871
IE - Irlanda 768
VN - Vietnam 698
UA - Ucraina 692
HK - Hong Kong 603
SE - Svezia 593
RU - Federazione Russa 501
BR - Brasile 499
DE - Germania 342
FI - Finlandia 241
KR - Corea 177
GB - Regno Unito 146
BE - Belgio 106
PL - Polonia 76
IN - India 61
TR - Turchia 60
FR - Francia 58
JP - Giappone 52
CA - Canada 51
AT - Austria 49
RO - Romania 41
NL - Olanda 40
MX - Messico 39
AR - Argentina 38
BD - Bangladesh 36
ES - Italia 30
CH - Svizzera 28
CZ - Repubblica Ceca 23
UZ - Uzbekistan 23
PK - Pakistan 19
ZA - Sudafrica 19
CI - Costa d'Avorio 14
ID - Indonesia 14
IQ - Iraq 13
EC - Ecuador 11
AE - Emirati Arabi Uniti 10
CL - Cile 9
SA - Arabia Saudita 9
IR - Iran 8
LB - Libano 8
LT - Lituania 8
PY - Paraguay 8
GR - Grecia 7
IL - Israele 7
KE - Kenya 7
EG - Egitto 6
MA - Marocco 5
CO - Colombia 4
DO - Repubblica Dominicana 4
EU - Europa 4
LV - Lettonia 4
PE - Perù 4
BG - Bulgaria 3
BH - Bahrain 3
JO - Giordania 3
LK - Sri Lanka 3
OM - Oman 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
TN - Tunisia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
Totale 17.590
Salva come PNG Salva come JPEG
Città #
Guangzhou 2.083
Singapore 1.218
Chandler 1.002
Dublin 768
Hong Kong 591
Dong Ket 503
Perugia 503
San Mateo 414
Jacksonville 356
Ashburn 307
Boardman 278
Santa Clara 238
Beijing 180
Medford 177
Princeton 176
Seoul 174
Ann Arbor 146
Wilmington 134
Altamura 125
Lawrence 111
Los Angeles 107
Moscow 107
Brussels 106
Munich 104
Andover 95
Ho Chi Minh City 83
New York 81
Piscataway 72
Fremont 66
The Dalles 60
West Jordan 58
São Paulo 54
Warsaw 50
Des Moines 47
Saint Petersburg 47
Tokyo 47
Turku 46
Redmond 43
Helsinki 42
Nanjing 40
Hanoi 37
Norwalk 34
Brooklyn 33
Vienna 33
Atlanta 32
Dallas 32
Woodbridge 31
Izmir 30
Orem 27
Bucharest 25
Chicago 25
Hefei 25
Denver 24
Chennai 22
Montreal 21
San Paolo di Civitate 21
Dearborn 20
Rio de Janeiro 20
Poplar 19
Redwood City 19
Falls Church 18
Houston 18
Ankara 17
Phoenix 17
Stockholm 17
Columbus 16
Rome 16
Shanghai 16
Spoleto 16
London 15
San Jose 15
Abidjan 14
Dhaka 14
Johannesburg 14
Mexico City 14
San Diego 14
Secaucus 14
Chongqing 13
Da Nang 13
Nuremberg 13
Philadelphia 13
Seattle 13
Hanover 12
Porto Alegre 12
Den Haag 11
Manchester 11
Olomouc 11
Toronto 11
Amsterdam 10
Belo Horizonte 10
Charlotte 10
San Francisco 10
Timisoara 10
Auburn Hills 9
Bologna 9
Boston 9
Brasília 9
Council Bluffs 9
Haiphong 9
Milan 9
Totale 11.880
Salva come PNG Salva come JPEG
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.124
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 310
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 302
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 291
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 289
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 232
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 173
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 155
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 147
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 139
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 132
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 126
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 125
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 123
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 122
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 120
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 118
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 116
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 114
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 113
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 113
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 112
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 111
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 111
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 111
6-Aminoquinolones as New Potential Anti-HIV Agents 109
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 109
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 108
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 108
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 106
6-Desfluoroquinolones as promising HIV transcription inhibitors 106
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 106
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 106
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 106
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 105
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 105
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 104
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 104
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 103
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 103
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 101
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 100
A New Derivative with Ultra-Potent Anti-HIV Activity 99
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 99
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 98
A new 6-aminoquinolone compound with anti-HCMV activity 97
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 97
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 97
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 96
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 96
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 96
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 96
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 95
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 95
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 95
QSAR study and VolSurf characterization of anti-HIV quinolone library 92
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 92
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 92
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 92
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. 91
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 91
S. aureus NorA efflux pump: the discovery of new potent inhibitors 91
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 91
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 90
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 90
6-Hydroxy Derivative as New Desfluoroquinolone (DFQ): Synthesis and DNA-binding Study 89
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 89
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 89
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 89
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 88
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 88
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 88
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 87
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 87
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 87
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 86
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 86
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 86
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 85
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 85
In Vitro Activities of New Quinolones Against Helicobacter pylori 84
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 84
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 84
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 84
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 84
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 83
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 83
Nuovi Tiopiranopiridinil Chinoloni 81
Antiviral 6-aminoquinolones: Molecolar basis for potency and selectivity. 81
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 81
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 81
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 80
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 78
New compounds targeting the rna polymerase of influenza a and b viruses. 78
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 77
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 77
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 76
Biotinylated Tryptophan Catabolites for Target Fishing. 74
Design and Synthesis of Modified Quinolones as Antitumoral Acridones 73
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 73
Totale 12.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.173 0 0 0 0 0 127 160 11 169 65 109 532
2021/20221.733 52 301 36 112 116 11 32 488 89 51 211 234
2022/20232.873 199 482 37 268 266 304 3 171 1.001 21 87 34
2023/20243.324 69 191 67 30 20 29 2.333 28 137 88 148 184
2024/20253.157 35 270 115 261 367 163 292 182 544 196 483 249
2025/20263.434 426 446 322 834 835 571 0 0 0 0 0 0
Totale 18.140